Just out from our group led by Annalisa Filtz and Andrea Scotti. Sex Disparities in Statin Use Following Coronary Computed Tomography Angiography academic.oup.com/eurjpc/article… Leslee Shaw Salim Virani Daniel Berman Damini Dey Ron Blankstein Michael D. Shapiro Carlos Gongora, MD FACC

🚨Job alert🚨Thrilled to share that the Gabr Lab received FIVE R01 grants for small molecule immunomodulators research. We are hiring postdocs with expertise in medicinal chemistry, neuropharmacology, or protein biochemistry. Applicants can send CVs to [email protected]

Today’s #Statistics wishes: 24 hours without propensity score analyses, invocations of the central limit theorem, closed testing procedures, random forests, lasso, feature selection in general, time to first event as a primary clinical trial endpoint, fixed sample sizes, ATE, …

Question regarding fantastic recent news of FINEARTS-HF reaching endpoint: Can I just use spironolactone or eplerenone to the same effect? tctmd.com/news/finearts-…

Out in AJPC “Bempedoic acid in secondary prevention” Could the differential impact of bempedoic acid in primary vs. secondary prevention cohorts be explained by differences in baseline characteristics of the two groups? doi.org/10.1016/j.ajpc…

#Statistics computing thought of the day: One of the most useful and powerful R #rstats packages you'll ever learn is data.table: hbiostat.org/rflow/manip Vanderbilt Department of Biostatistics

Diagnostic performance measures in clinical medicine (R2, AUC, OR) are all mathematically related, but far from linearly. I made these figs to discuss w my PhD students. Venk Murthy MD PhD Brett Atwater Hause Lin source data: escal.site

Martin Ugander Venk Murthy MD PhD Brett Atwater Hause Lin Good visualization, thank you. Maybe what I’ve added below will be complementary.

Digital Health: From Remote Monitoring to Remote Care Journal of Cardiac Failure 1/ The rise of Digital Health Technology introduced new solutions that aim to enhance patient care. But so far, the focus has largely been on passive monitoring, leading to challenges in clinical integration🤖📊

Very proud of our Houston Methodist Cardiovascular Fellowships who have 10 accepted presentations #TCT2024. Come join us in DC this October. Stephen Little, MD Nadeen N. Faza, M.D. Joe Aoun Michael Reardon MATKINS Houston Methodist CV Ju Kim WilliamZoghbi Dipan J. Shah, MD Carlos El-Tallawi, MD “HeartToProve” Sherif F Nagueh Cindy M. Martin Valeria Duarte MD MPH

Couldn't be more proud of my cardiovascular fellow Marco Bernardi, who has masterfully presented his on cardiac MRI at #ESCCongress2024 Marco Bernardi

Does elevated LDL cause aortic stenosis? 🥓🫀🩺 Excited to share our study linking rare LDL-associated genetic variants to aortic stenosis 🧬 Published in @Circulation and presented at #ESCCongress2024 today Broad Institute UCSF Health Link: ahajournals.org/doi/10.1161/CI…

Pleased to share our analysis in Annals of Int Med ->Cardiovascular risk classification of US adults using PCE vs PREVENT ->PREVENT predominantly yields lower risk estimates and reduces the number of individuals at increased risk categories compared to the PCE

"Excited to present our research from MD Anderson Cancer Center on Coronary Flow Dynamics and Cardiovascular Outcomes in Cancer Patients at ASNC Society. 🌟 Profound gratitude to mentors Cezar Iliescu & Shaden Khalaf, M.D. for their guidance. 📊💓 #ASNC2024 #CardioOncology"

Very interesting presentation from Bhattaru et al on the use of radioomics with F18-Florbetapir to characterize unique disease patterns in patients with amyloid who are treated with plasma cell therapy. #ASNC2024 #CVNuc #ThinkPET

Great cases today by Dr. Rameez on the use of low MFR/high to identify balanced ischemia, absence of splenic switch off to identify regadenoson non-response and low MFR/zero CAC to identify microvascular dysfunction. #ASNC2024 #CVNuc #ThinkPET